Toda and colleagues used a murine granulocyte-macrophage colony-stimulating factor (GM-CSF)-encoding HSV-1 amplicon packaged using a mutant helper virus (tsK) to treat a bilateral subcutaneous tumor model of Harding-Passey murine melanoma [124]. This evidence concerns the gene CSF2 and melanoma.